Power Law company profile

Cidara Therapeutics

Biotech & Life Sciences · San Diego, United States · Founded 2012 · IPO 2015 Unicorn

Cidara Therapeutics is developing innovative therapies

Valuation

$9.20B

Market cap · Jan/2026

Revenue

$1.3M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

12 investors on Cidara Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 4 investors entered at this stage

InterWest Partners

Aisling Capital

Frazier Healthcare Partners

5AM Ventures

Series B+ 8 investors entered at this stage

Spruce Street Capital

TCGX

Vivo Capital

Adage Capital

BVF Partners

RA Capital Management

Checkpoint Capital

Venrock

Global footprint

Where Cidara Therapeutics has talent and traffic

Workforce by country

🇺🇸 United States · San Diego HQ

Book a demo for the full country breakdown

Web traffic by country

7.8K monthly visits
across markets

🇺🇸 United States53.8%

🇬🇧 United Kingdom16.7%

🇹🇼 Taiwan15.4%

🇮🇳 India14.1%

Top 4 markets shown

Market sentiment

What the market is saying about Cidara Therapeutics

An AI-synthesized read of the highest-engagement posts about Cidara Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cidara Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles